United Therapeutics Corporation FDA Record
- Latest inspection VAI · Feb 28, 2025
- No warning letters matched by name
United Therapeutics Corporation has 3 FDA recalls, 14 inspections, 1 510(k) clearance and 0 compliance actions on record. No FDA warning letter addressed to "United Therapeutics Corporation" is on file.
- Latest recall
- D-1188-2018 · Class III · Aug 14, 2018
- Latest inspection
- Feb 28, 2025 · VAI
- Latest 510(k)
- Feb 19, 2016
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 3 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 1 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 14 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
United Therapeutics Corporation: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 0 | 0 | 1 | 0 |
| 2017 | 2 | 0 | 0 | 1 | 0 |
Reviewing United Therapeutics Corporation as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check United Therapeutics Corporation yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1188-2018 | Class III | Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil) Inhalation Solution… | Aug 14, 2018 |
| D-0083-2018 | Class II | TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation… | Sep 11, 2017 |
| D-1423-2014 | Class II | Tyvaso (treprostinil) Inhalation Solution, Treprostinil 1.74 mg/2.9 mL, Four 2.9 mL Ampules, For… | Mar 28, 2014 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Feb 28, 2025 | Durham, NC | Drugs | Voluntary Action Indicated (VAI) | 3003825766 |
| May 2, 2024 | Silver Spring, MD | Drugs | Voluntary Action Indicated (VAI) | 3003368324 |
| May 3, 2018 | Durham, NC | Drugs | No Action Indicated (NAI) | 3003825766 |
| Mar 31, 2017 | Silver Spring, MD | Drugs | Voluntary Action Indicated (VAI) | 3003368324 |
| Feb 24, 2017 | Durham, NC | Drugs | No Action Indicated (NAI) | 3003825766 |
| Aug 21, 2015 | Durham, NC | Drugs | Voluntary Action Indicated (VAI) | 3003825766 |
| Jul 11, 2014 | Silver Spring, MD | Drugs | No Action Indicated (NAI) | 3003368324 |
| Sep 27, 2013 | Durham, NC | Drugs | No Action Indicated (NAI) | 3003825766 |
| May 29, 2013 | Silver Spring, MD | Drugs | Voluntary Action Indicated (VAI) | 3003368324 |
| Aug 2, 2012 | Durham, NC | Drugs | No Action Indicated (NAI) | 3003825766 |
| Dec 12, 2011 | Silver Spring, MD | Drugs | No Action Indicated (NAI) | 3003368324 |
| Jun 28, 2011 | Silver Spring, MD | Drugs | No Action Indicated (NAI) | 3003368324 |
| Feb 11, 2011 | Silver Spring, MD | Drugs | Voluntary Action Indicated (VAI) | 3003368324 |
| Nov 7, 2008 | Silver Spring, MD | Drugs | Voluntary Action Indicated (VAI) | 3003368324 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3003825766 | Durham, NC | 6 | Feb 28, 2025 |
| FEI 3003368324 | Silver Spring, MD | 8 | May 2, 2024 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K153384 | Low Potassium Dextran Solution with Tris Diluent | Feb 19, 2016 |
United Therapeutics Corporation and the FDA: common questions
Has United Therapeutics Corporation received an FDA warning letter?
No FDA warning letter addressed to the name "United Therapeutics Corporation" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has United Therapeutics Corporation received an FDA Form 483?
FDA has not published a Form 483 for "United Therapeutics Corporation" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect United Therapeutics Corporation?
The most recent FDA inspection on file ended Feb 28, 2025 at Durham, NC and was classified VAI. FDA has 14 inspections of United Therapeutics Corporation on file.
Has United Therapeutics Corporation had an FDA recall?
Yes. United Therapeutics Corporation has 3 FDA recalls on record. The most recent started Aug 14, 2018.
Need more than this page shows? Ask about United Therapeutics Corporation in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.